As a child, your parents may have told you to mind your manners—to say please and thank yo...
Chilean Environment Ministry suspends 43 measures touching on issues such as pollution, em...
Al Pacino and his on-again, off-again girlfriendNoor Alfallah are raising a little one tog...
The ratings weren't exactly golden for this year's Oscars: The 2026 telecast hosted by Con...
The Red Sox reached agreement with veteran reliever Tommy Kahnle on a minor league contrac...
Countries
Opinion
Rachel Zegler’s latest victim act slights J. Lo, Eva Mendes and other Latina stars
US allies need to get a grip – step up and help open the Strait of Hormuz
Political Turmoil: Peru's Prime Minister Denisse Miralles Resigns
- japan times ( Middle East ) 2025/12/12
Just two drugs are widely approved to slow Alzheimer's — Eli Lilly's Kisunla and Leqembi from Eisai and Biogen.
- INDEPENDENT ( United Arab Emirates ) 2025/12/6
A bacteria best known for causing stomach ulcers could lead to a new strategy in the fight against Alzheimer’s disease
- PR Newswire ( Middle East ) 2025/12/4
Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate Alzheimer's dis...
- mercury news ( Middle East ) 2025/12/2
For years, Los Altos resident Kim Wilford watched Alzheimer’s Disease rob her beloved mother-in-law of her memories, spirit and finally, her...
- Mail Online ( Middle East ) 2025/12/1
Liraglutide - sold under the brand name Saxenda - is often offered to people with with a BMI of over 30 as it improves blood sugar control a...
- Time ( Middle East ) 2025/11/24
GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the drugs affect th...
- Devdiscourse ( Middle East ) 2025/11/24
Novo Nordisk has announced the failure of its Alzheimer's trials, where an older oral version of their semaglutide drug did not succeed in s...
- Gizmodo ( Middle East ) 2025/11/24
An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.
- PR Newswire ( Middle East ) 2025/11/24
Data provides new insights into targeting the diverse pathobiology of Alzheimer's disease, an approach spearheaded by the ADDF NEW YORK, Nov...
-
Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says
News channel ( Middle East ) 2025/11/24By Jamie Gumbrecht, CNN(CNN) — An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to s...
- Time ( Middle East ) 2025/11/19
When actor Chris Hemsworth, who played Thor in the Marvel series, agreed to join a documentary exploring longevity several years ago, he fig...
- Mail Online ( Middle East ) 2025/11/18
A panel of academics, doctors and patients examined 80 existing treatments to identify those mostly likely to help tackle Alzheimer's - for...
- Independent ( Yemen ) 2025/11/18
Scientists hail ‘very exciting’ findings that explain why Alzheimer’s patients forget their loved ones, and say drugs are already available...
- PR Newswire ( Middle East ) 2025/11/17
HONG KONG, Nov. 16, 2025 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) announced that its AK152, a novel bispecific antibody targeting both am...
- Fortune ( Middle East ) 2025/11/10
Bill Gates wants to add a new element to routine medicals for Americans over the age of 60: Blood tests that identify whether the patient ma...